Pro Share Advisors LLC Immunovant, Inc. Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Immunovant, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 19,619 shares of IMVT stock, worth $539,718. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,619

Previous 16,244 20.78%

Holding current value

$539,718

Previous $428,000 25.93%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$27.51 - $27.51 $92,846 - $92,846	3,375 Added 20.78%	19,619 $539,000
Q2 2024 Aug 13, 2024	SELL	$25.1 - $31.61 $91,188 - $114,839	-3,633 Reduced 18.28%	16,244 $428,000
Q1 2024 May 08, 2024	BUY	$30.27 - $43.79 $51,549 - $74,574	1,703 Added 9.37%	19,877 $642,000
Q4 2023 Feb 14, 2024	BUY	$31.31 - $44.19 $82,032 - $115,777	2,620 Added 16.84%	18,174 $765,000
Q3 2023 Nov 13, 2023	BUY	$18.55 - $39.96 $1,836 - $3,956	99 Added 0.64%	15,554 $597,000
Q2 2023 Aug 10, 2023	BUY	$14.2 - $23.75 $16,940 - $28,333	1,193 Added 8.36%	15,455 $293,000
Q1 2023 May 11, 2023	SELL	$15.27 - $19.72 $32,784 - $42,338	-2,147 Reduced 13.08%	14,262 $221,000
Q4 2022 Feb 02, 2023	BUY	$6.59 - $17.75 $14,405 - $38,801	2,186 Added 15.37%	16,409 $291,000
Q3 2022 Nov 04, 2022	BUY	$3.93 - $6.37 $2,589 - $4,197	659 Added 4.86%	14,223 $80,000
Q2 2022 Aug 01, 2022	SELL	$3.38 - $5.65 $20,584 - $34,408	-6,090 Reduced 30.99%	13,564 $53,000
Q1 2022 May 10, 2022	SELL	$5.06 - $8.77 $26,823 - $46,489	-5,301 Reduced 21.24%	19,654 $108,000
Q4 2021 Feb 08, 2022	SELL	$7.33 - $9.32 $34,788 - $44,232	-4,746 Reduced 15.98%	24,955 $212,000
Q3 2021 Nov 12, 2021	BUY	$7.01 - $11.37 $16,585 - $26,901	2,366 Added 8.66%	29,701 $258,000
Q2 2021 Aug 13, 2021	BUY	$9.4 - $16.85 $35,325 - $63,322	3,758 Added 15.94%	27,335 $289,000
Q1 2021 May 14, 2021	BUY	$13.08 - $49.6 $2,118 - $8,035	162 Added 0.69%	23,577 $378,000
Q4 2020 Feb 09, 2021	BUY	$36.36 - $52.71 $851,369 - $1.23 Million	23,415 New	23,415 $1.08 Million

Others Institutions Holding IMVT

# of Institutions

211

Shares Held

66M

Call Options Held

2.3M

Put Options Held

631K

View Full List

About Immunovant, Inc.

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

More about IMVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Immunovant, Inc. Transaction History